Differential diagnosis of dementia with lewy bodies and alzheimer disease using combined MR imaging and brain perfusion single-photon emission tomography

American Journal of Neuroradiology

Volumn 31, Issue 4, 2010, Pages 720-725

  Goto, H ^a   Ishii, K ^a,b   Uemura, T ^a   Miyamoto, N ^a   Yoshikawa, T ^a   Shimada, K ^a   Ohkawa, S ^a  

^a Hyogo Brain and Heart Center   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IOFETAMINE I 123;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN PERFUSION; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OCCIPITAL CORTEX; RADIODIAGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; CORPUS STRIATUM; DIAGNOSIS, DIFFERENTIAL; FEMALE; HIPPOCAMPUS; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; LEWY BODY DISEASE; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; OCCIPITAL LOBE; ORGAN SIZE; REFERENCE VALUES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77950790000     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1926     Document Type: Article

References (53)

1. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65: 1863-1872 Epub 2005 Oct 19 (Pubitemid 43970103)
2. Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 1990;40:1-8 (Pubitemid 20032882)
3. Kosaka K. Diffuse Lewy body disease in Japan. J Neurol 1990;237:197-204 (Pubitemid 20209309)
4. Galasko D. Lewy bodies and dementia. Curr Neurol Neurosci Rep 2001;1:435-441
5. Zesiewicz TA, Baker MJ, Dunne PB, et al. Diffuse Lewy body disease. Curr Treat Options Neurol 2001;3:507-518
6. Doubleday EK, Snowden JS, Varma AR, et al. Qualitative performance characteristics differentiate dementia with Lewy bodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002;72:602-607 (Pubitemid 34462814)
7. Mega MS, Lee L, Dinov ID, et al. Cerebral correlates of psychotic symptoms in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2000;69:167-171 (Pubitemid 30466019)
8. Ishii K, Imamura T, Sasaki M, et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology 1998;51:125-130 (Pubitemid 28345371)
9. Ishii K, Yamaji S, Kitagaki H, et al. Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology 1999;53:413-416 (Pubitemid 29344372)
10. Lobotesis K, Fenwick JD, Phipps A, et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 2001;56:643-649 (Pubitemid 32209999)
11. Ransmayr G, Seppi K, Donnemiller E, et al. Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease. Eur J Nucl Med 2001;28:1523-1528 (Pubitemid 32938402)
12. Piggott MA, Marshall EF, Thomas N, et al. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Brain 1999;122:1449-1468 (Pubitemid 29374123)
13. Petrella JR, Coleman RE, Doraiswamy PM. Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. Radiology 2003;226:315-336 (Pubitemid 36313415)
14. Ishii K, Soma T, Kono AK, et al. Comparison of regional brain volume and glucose metabolism between patients with mild dementia with Lewy bodies and those with mild Alzheimer's disease. J Nucl Med 2007;48:704-711 (Pubitemid 47604969)
15. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944 (Pubitemid 14076461)
16. McKeith IG, Galasko D, Kosaka, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124
17. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314 (Pubitemid 24382728)
18. Defebvre LJ, Leduc V, Duhamel A, et al. Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease. J Nucl Med 1999;40:956-962 (Pubitemid 29269214)
19. Minoshima S, Foster NL, Sima AA, et al. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol 2001;50:358-365 (Pubitemid 32848738)
20. Shimizu S, Hanyu H, Kanetaka H, et al. Differentiation of dementia with Lewy bodies from Alzheimer's disease using brain SPECT. Dement Geriatr Cogn Disord 2005;20:25-30 (Pubitemid 40981174)
21. Pasquier J, Michel BF, Brenot-Rossi I, et al. Value of (99m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies. Eur J Nucl Med Mol Imaging 2002;29:1342-1348 Epub 2002 Jul 31 (Pubitemid 44392216)
22. mTc HmPAO SPECT data. J Neurol Neurosurg Psychiatry 2000;69:661-663
23. McNeill R, Sare GM, Manoharan M, et al. Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease. J Neurol Neurosurg Psychiatry 2007;78:350-355
24. Sjögren M, Gustafson L, Wikkelsö C, et al. Frontotemporal dementia can be distinguished from Alzheimer's disease and subcortical white matter dementia by an anterior-to-posterior rCBF-SPET ratio. Dement Geriatr Cogn Disord 2000;11:275-285
25. mTc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. Eur J Nucl Med Mol Imaging 2002;29:615-622 Epub 2002 Mar 5
26. Kemp PM, Hoffmann SA, Tossici-Bolt L, et al. Limitations of the HMPAO SPECT appearances of occipital lobe perfusion in the differential diagnosis of dementia with Lewy bodies. Nucl Med Commun 2007;28:451-456
27. O'Brien JT. Role of imaging techniques in the diagnosis of dementia. Br J Radiol 2007;80:S71-77
28. 123I-FP-CITSPECTin dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol 2007;6:305-313
29. O'Brien JT, Colloby S, Fenwick J, et al. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol 2004;61:919-925
30. 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies. Int Psychogeriatr 2008;20:1124-1140
31. 123I-FP-CIT SPECT. Eur J Nucl Med Mol Imaging 2005;32:1176-1185 Epub 2005 Jun 2
32. Tatsch K. Imaging of the dopaminergic system in differential diagnosis of dementia. Eur J Nucl Med Mol Imaging 2008;35(suppl 1):S51-57
33. O'Brien JT, McKeith IG, Walker Z, et al. Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies. Br J Psychiatry 2009;194:34-39
34. mTc-HMPAO-SPECT in dementia. Am J Geriatr Psychiatry 2004;12:554-570
35. Ishii K, Hosaka K, Mori T, et al. Comparison of FDG-PET and IMP-SPECT in patients with dementia with Lewy bodies. Ann Nucl Med 2004;18:447-451
36. Hanyu H, Shimizu S, Hirao K, et al. Comparative value of brain perfusion SPECTand [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease. Eur J Nucl Med Mol Imaging 2006;33:248-253
37. Hanyu H, Shimizu S, Hirao K, et al. Differentiation of dementia with Lewy bodies from Alzheimer's disease using Mini-Mental State Examination and brain perfusion SPECT. J Neurol Sci 2006;250:97-102
38. Kitayama N, Matsuda H, Ohnishi T, et al. Measurements of both hippocampal blood flow and hippocampal gray matter volume in the same individuals with Alzheimer's disease. Nucl Med Commun 2001;22:473-477 (Pubitemid 32458173)
39. Barber R, McKeith I, Ballard C, et al. Volumetric MRI study of the caudate nucleus in patients with dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. J Neurol Neurosurg Psychiatry 2002;72:406-407
40. Almeida OP, Burton EJ, McKeith I, et al. MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord 2003;16:57-63 (Pubitemid 36677097)
41. Rombouts SA, Barkhof F, Witter MP, et al. Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease. Neurosci Lett 2000;285:231-233 (Pubitemid 30252070)
42. Whitwell JL, Weigand SD, Shiung MM, et al. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. Brain 2007;130:708-719
43. Cousins DA, Burton EJ, Burn D, et al. Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer's disease: an MRI study. Neurology 2003;61:1191-1195 (Pubitemid 37377536)
44. Katsuse O, Iseki E, Marui W, et al. Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies. J Neurol Sci 2003;211:29-35 (Pubitemid 36593264)
45. Higuchi M, Tashiro M, Arai H, et al. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies. Exp Neurol 2000;162:247-256 (Pubitemid 30217720)
46. Zaja-Milatovic S, Keene CD, Montine KS, et al. Selective dendritic degeneration of medium spiny neurons in dementia with Lewy bodies. Neurology 2006;66:1591-1593 (Pubitemid 43958566)
47. Zaja-Milatovic S, Milatovic D, Schantz AM, et al. Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurology 2005;64:545-547 (Pubitemid 40189880)
48. Lisanby SH, McDonald WM, Massey EW, et al. Diminished subcortical nuclei volumes in Parkinson's disease by MR imaging. J Neural Transm Suppl 1993;40:13-21
49. Krabbe K, Karlsborg M, Hansen A, et al. Increased intracranial volume in Parkinson's disease. J Neurol Sci 2005;239:45-52 (Pubitemid 41617414)
50. Geng DY, Li YX, Zee CS. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease. Neurosurgery 2006;58:256-262
51. Jack CR Jr, Petersen RC, O'Brien PC, et al. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-188
52. Pennanen C, Kivipelto M, Tuomainen S, et al. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging 2004;25:303-310 (Pubitemid 38220965)
53. Barber R, Gholkar A, Scheltens P, et al. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology 1999;52:1153-1158 (Pubitemid 29177914)